Balyasny Asset Management LLC Roivant Sciences Ltd. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$10.36 - $11.74 $3.89 Million - $4.41 Million
375,411 New
375,411 $3.97 Million
Q4 2023

Feb 14, 2024
BUY
$8.38 - $11.58 $3.02 Million - $4.18 Million
360,551 New
360,551 $4.05 Million
Q3 2022

Nov 14, 2022
BUY
$0.51 - $4.84 $733,364 - $6.96 Million
1,437,970 Added 456.15%
1,753,210 $5.65 Million
Q2 2022

Aug 15, 2022
BUY
$2.81 - $4.84 $885,824 - $1.53 Million
315,240 New
315,240 $1.28 Million

Others Institutions Holding ROIV

# of Institutions
311
Shares Held
508M
Call Options Held
1.26M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.95B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email